Show
Sort by
-
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury
-
Mechanisms and in vitro models of drug-induced cholestasis
-
Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease
-
Strategies for determining correct cytochrome P450 contributions in hepatic clearance predictions : in vitro-in vivo extrapolation as modelling approach and tramadol as proof-of concept compound
-
Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects : a stable isotope study